QIAGEN NV (QGEN)
48.32
-0.71
(-1.45%)
USD |
NYSE |
Feb 19, 16:00
48.32
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 9.954B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 29.69% |
| Valuation | |
| PE Ratio | 23.64 |
| PE Ratio (Forward) | |
| PS Ratio | 4.807 |
| Price to Book Value | 2.635 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 2.29 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.4379 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 37.44% |
Profile
| QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands. |
| URL | http://www.qiagen.com |
| Investor Relations URL | https://corporate.qiagen.com/investor-relations/overview |
| HQ State/Province | Limburg |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | May. 06, 2026 (est.) |
| Last Earnings Release | Feb. 04, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jan. 08, 2026 |
Profile
| QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands. |
| URL | http://www.qiagen.com |
| Investor Relations URL | https://corporate.qiagen.com/investor-relations/overview |
| HQ State/Province | Limburg |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | May. 06, 2026 (est.) |
| Last Earnings Release | Feb. 04, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jan. 08, 2026 |